Literature DB >> 3188378

Platelet activating factor as a mediator of equine cell locomotion.

J Dawson1, P Lees, A D Sedgwick.   

Abstract

Equine polymorphonuclear (PMN) and mononuclear (MN) leucocytes were separated on Percoll gradients and used to study the chemoattractant properties of the polar ether-linked phospholipid, platelet activating factor (PAF). Six concentrations of PAF ranging from 1 ng/ml to 100 micrograms/ml were studied in each of two in vitro assay systems, the agarose microdroplet and a microfilter technique. Very significant (p less than 0.01) increases in the movement of both PMN and MN cells were obtained with most concentrations of PAF. In two instances there was no apparent concentration-response relationship, although the action of PAF was approximately bell-shaped in two others. The possible significance of these findings for equine inflammatory conditions is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3188378     DOI: 10.1007/bf00362788

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  19 in total

1.  Single step purification procedure for the rapid separation of equine leucocytes.

Authors:  A D Sedgwick; T Morris; B A Russell; P Lees
Journal:  Vet Res Commun       Date:  1986-11       Impact factor: 2.459

2.  The role of platelet-activating factor in platelet aggregation.

Authors:  M Chignard; J P Le Couedic; M Tence; B B Vargaftig; J Benveniste
Journal:  Nature       Date:  1979-06-28       Impact factor: 49.962

3.  The release of a platelet-activating factor by stimulated rabbit neutrophils.

Authors:  J M Lynch; G Z Lotner; S J Betz; P M Henson
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

4.  Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

Authors:  B B Vargaftig; J Lefort; M Chignard; J Benveniste
Journal:  Eur J Pharmacol       Date:  1980-07-25       Impact factor: 4.432

5.  Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

Authors:  L M McManus; D J Hanahan; C A Demopoulos; R N Pinckard
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  Influence of chemotactic agents on the locomotion of equine polymorphonuclear and mononuclear leucocytes.

Authors:  A D Sedgwick; J Dawson; P Lees
Journal:  Res Vet Sci       Date:  1987-07       Impact factor: 2.534

7.  Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.

Authors:  N K Hopkins; R G Schaub; R R Gorman
Journal:  Biochim Biophys Acta       Date:  1984-09-14

8.  Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit.

Authors:  M Halonen; J D Palmer; I C Lohman; L M McManus; R N Pinckard
Journal:  Am Rev Respir Dis       Date:  1981-10

9.  Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes.

Authors:  J M Mencia-Huerta; J Benveniste
Journal:  Eur J Immunol       Date:  1979-05       Impact factor: 5.532

10.  The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis.

Authors:  M J Smith; J R Walker
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

View more
  1 in total

1.  The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.

Authors:  B J McEwen; B P Wilcock; P Eyre
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.